Growth Metrics

Collegium Pharmaceutical (COLL) Non-cash Items (2016 - 2025)

Collegium Pharmaceutical has reported Non-cash Items over the past 11 years, most recently at $493716.0 for Q3 2025.

  • For Q3 2025, Non-cash Items fell 27.83% year-over-year to $493716.0; the TTM value through Sep 2025 reached $493716.0, down 27.83%, while the annual FY2024 figure was $6.6 million, 50.11% down from the prior year.
  • Non-cash Items for Q3 2025 was $493716.0 at Collegium Pharmaceutical, down from $76.7 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $82.4 million in Q1 2025 and troughed at $493716.0 in Q3 2025.
  • A 5-year average of $24.5 million and a median of $6.6 million in 2024 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: tumbled 98.4% in 2024 and later surged 10970.1% in 2025.
  • Year by year, Non-cash Items stood at $6.1 million in 2021, then skyrocketed by 31.02% to $8.0 million in 2022, then soared by 67.19% to $13.3 million in 2023, then plummeted by 50.11% to $6.6 million in 2024, then tumbled by 92.56% to $493716.0 in 2025.
  • Business Quant data shows Non-cash Items for COLL at $493716.0 in Q3 2025, $76.7 million in Q2 2025, and $82.4 million in Q1 2025.